BURLINGTON, Ontario–(BUSINESS WIRE)–Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) has completed its previously announced reclassification (the “Reclassification”) of its subordinate voting shares as common shares (the “Common Shares”) of the Company. The Common Shares will be assigned CUSIP number 03253E206 and ISIN number CA03253E2069 following the Reclassification.
The Common Shares will begin trading on a post-Reclassification basis under the new CUSIP and ISIN numbers on the Toronto Stock Exchange (“TSX”) at market open on or about August 23, 2024, under the existing trading symbol. Additionally, the multiple voting shares, of which none are outstanding, have since been removed from the authorized share structure of the Company.
“We are pleased that the Company’s dual-class share structure has been eliminated,” said Ohad Epschtein, Executive Chairman of Anaergia. “This change better aligns the interests of all of Anaergia’s shareholders, as the Company focuses on its vision of being the world’s leading renewable fuel producer,” added Mr. Epschtein.
About Anaergia
Anaergia was created to eliminate a major source of greenhouse gases (“GHGs”) by cost effectively turning organic waste into renewable natural gas (“RNG”), fertilizer and water through the use of proprietary technologies. With a track record of delivering innovative projects, Anaergia is uniquely positioned to provide solutions to today’s most pressing resource recovery challenges using a broad portfolio of proven technologies and multiple project delivery methods. Anaergia is one of the world’s only companies with a proprietary portfolio of end-to-end solutions that integrate solid waste processing as well as wastewater treatment with organics recovery, high efficiency anaerobic digestion, RNG production and recovery of fertilizer and water from organic residuals. The combination of these technologies enhances carbon-negative biogas, clean water and natural fertilizer production, utilizes a minimized footprint and lowers waste and wastewater treatment costs and GHG emissions.
For further information please see: www.anaergia.com
Forward-Looking Statements
This news release contains forward-looking information within the meaning of applicable securities legislation, which reflects Anaergia’s current expectations regarding future events, including but not limited to, statements regarding the expectation that the Common Shares will resume trading on the TSX on or about August 23, 2024. Forward-looking information is based on a number of assumptions, including, but not limited to the timing that trading of the Common Shares will resume on the TSX. The Company is subject to a number of risks and uncertainties, many of which are beyond the Company’s control. Such risks and uncertainties include, but are not limited to, the factors discussed under “Risk Factors” in the Company’s annual information form for the fiscal year ended December 31, 2023, and under “Risks and Uncertainties” in the Company’s most recent management’s discussion and analysis. Actual results could differ materially from those projected herein. Anaergia does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required under applicable securities laws. Additional information on these and other factors that could affect Anaergia’s operations or financial results are included in Anaergia’s reports on file with Canadian regulatory authorities.
Contacts
For media and/or investor relations please contact: IR@Anaergia.com
